Named on 2 rounds in the feed.
Rounds from 2025-11-20 to 2026-06-10
ROUNDS
2
joined, none as lead
ROUNDS JOINED · USD
$240M
across 2 rounds
CO-INVESTORS
25
most often with Arch Venture Partners
Named on 2 rounds in the feed.
Rounds from 2025-11-20 to 2026-06-10
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
SonoThera SonoThera develops innovative ultrasound-mediated nonviral genetic therapies targeting various medical conditions. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $125M | 2026-06-10 | [ PART ] |
Aspen Neuroscience Aspen Neuroscience develops personalized regenerative therapies, specifically autologous iPSC-derived cell replacement therapies for Parkinson's disease. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $115M | 2025-11-20 | [ PART ] |